Home Tools
Log in
Cart

GSK1838705A

Catalog No. T3079   CAS 1116235-97-2

GSK1838705A is an effective IGF-1R inhibitor (IC50: 2.0 nM), modestly potent to IR (IC50: 1.6 nM) and ALK (IC50: 0.5 nM), respectively, and little inhibition to other protein kinases.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.
GSK1838705A Chemical Structure
GSK1838705A, CAS 1116235-97-2
Pack Size Availability Price/USD Quantity
1 mg In stock $ 34.00
2 mg In stock $ 48.00
5 mg In stock $ 77.00
10 mg In stock $ 133.00
25 mg In stock $ 280.00
50 mg In stock $ 506.00
1 mL * 10 mM (in DMSO) In stock $ 89.00
Bulk Inquiry
Get quote
Select Batch  
Purity: 100%
Purity: 99.63%
Purity: 98.89%
Contact us for more batch information
Biological Description
Chemical Properties
Storage & Solubility Information
Description GSK1838705A is an effective IGF-1R inhibitor (IC50: 2.0 nM), modestly potent to IR (IC50: 1.6 nM) and ALK (IC50: 0.5 nM), respectively, and little inhibition to other protein kinases.
Targets&IC50 ALK:0.5 nM, IGF-1R:2 nM, Insulin receptor:1.6 nM
In vitro In mice carrying COLO 205 tumors, GSK1838705A (30 mg/kg) inhibits 80% of tumor growth. Additionally, GSK1838705A demonstrates antitumor activity in mice with HT29 or BxPC3 xenografts. In mice with NIH-3T3/LISN tumors, GSK1838705A (60 mg/kg, p.o.) suppresses 77% of tumor growth without significant weight loss. It also momentarily doubles blood glucose levels by inhibiting IR signaling at a dose of 60 mg/kg. Furthermore, GSK1838705A (60 mg/kg) inhibits growth in established Karpas-299 xenografts by 93%, with no adverse effects on rat weight.
In vivo GSK1838705A effectively inhibits the phosphorylation of IGF-1R (IC50: 85 nM) and IR (IC50: 79 nM) induced by ligands in cells. It demonstrates significant antiproliferative effects on various cell lines derived from solid and hematological tumors, such as L-82, SUP-M2, SK-ES, and MCF-7 (EC50: 24/28/141/203 nM). GSK1838705A induces the accumulation of MCF-7 and NCI-H929 cells in the G1 (2N) phase of the cell cycle. Additionally, it inhibits ALK (Ki: 0.35 nM) and the proliferation of cells expressing the NPM-ALK fusion protein (EC50: 24-88 nM). GSK1838705A significantly suppresses the phosphorylation of NPM-ALK in Karpas-299 and SR-786 cells, though it exhibits moderate effects on the phosphorylation of STAT3.
Kinase Assay Kinase Assays: Baculovirus-expressed glutathione S-transferase-tagged proteins encoding the intracellular domain of IGF-1R (amino acids 957-1367) and IR (amino acids 979-1382) are used for determinations of IC50s by a homogeneous time-resolved fluorescence assay. A filter binding assay is used for appKi determinations using activated IGF-1R and IR kinases. Expanded kinase-selectivity profiling of GSK1838705A is carried out by screening the compound in the KinaseProfiler panel.
Cell Research Cells are seeded in 96-well dishes, incubated overnight at 37 °C, and treated with DMSO or GSK1838705A for 72 hours. For the NIH-3T3/LISN proliferation assays, cells are seeded on collagen-coated 96-well tissue culture plates and allowed to adhere for 24 hours. The medium is replaced with serum-free medium and the cells are treated with GSK1838705A for 2 hour. Cells are incubated for 72 hours after addition of IGF-I (30 ng/mL). Cell proliferation is quantified using the CellTiter-Glo Luminescent Cell Viability Assay. IC50s are determined from cytotoxicity curves using a four-parameter curve fit software package (XLfit4(Only for Reference)
Molecular Weight 532.57
Formula C27H29FN8O3
CAS No. 1116235-97-2

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

Solubility Information

DMSO: 53.3 mg/mL (100 mM)

TargetMolReferences and Literature

1. Sabbatini P, et al. Mol Cancer Ther. 2009, 8(10), 2811-2820.

Related compound libraries

This product is contained In the following compound libraries:
Anti-Cancer Active Compound Library Tyrosine Kinase Inhibitor Library Anti-Neurodegenerative Disease Compound Library Inhibitor Library Kinase Inhibitor Library Angiogenesis related Compound Library Anti-Lung Cancer Compound Library Cancer Cell Differentiation Compound Library Anti-Obesity Compound Library Osteogenesis Compound Library

Related Products

Related compounds with same targets
GIP (1-30) amide, porcine acetate MID-1 I-OMe-Tyrphostin AG 538 PD173074 AZD-3463 Veligrotug PQ401 Insulin (human)

TargetMolDose Conversion

You can also refer to dose conversion for different animals. More

TargetMol In vivo Formulation Calculator (Clear solution)

Step One: Enter information below
Dosage
mg/kg
Average weight of animals
g
Dosing volume per animal
ul
Number of animals
Step Two: Enter the in vivo formulation
% DMSO
%
% Tween 80
% ddH2O
Calculate Reset

TargetMolCalculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculation
Molecular Weight Calculator
=
X
X

Molarity Calculator allows you to calculate the

  • Mass of a compound required to prepare a solution of known volume and concentration
  • Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Concentration of a solution resulting from a known mass of compound in a specific volume
See Example

An example of a molarity calculation using the molarity calculator
What is the mass of compound required to make a 10 mM stock solution in 10 ml of water given that the molecular weight of the compound is 197.13 g/mol?
Enter 197.13 into the Molecular Weight (MW) box
Enter 10 into the Concentration box and select the correct unit (millimolar)
Enter 10 into the Volume box and select the correct unit (milliliter)
Press calculate
The answer of 19.713 mg appears in the Mass box

X
=
X

Calculator the dilution required to prepare a stock solution

Calculate the dilution required to prepare a stock solution
The dilution calculator is a useful tool which allows you to calculate how to dilute a stock solution of known concentration. Enter C1, C2 & V2 to calculate V1.

See Example

An example of a dilution calculation using the Tocris dilution calculator
What volume of a given 10 mM stock solution is required to make 20ml of a 50 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=50 μM, V2=20 ml and V1 is the unknown:
Enter 10 into the Concentration (start) box and select the correct unit (millimolar)
Enter 50 into the Concentration (final) box and select the correct unit (micromolar)
Enter 20 into the Volume (final) box and select the correct unit (milliliter)
Press calculate
The answer of 100 microliter (0.1 ml) appears in the Volume (start) box

=
/

Calculate the volume of solvent required to reconstitute your vial.

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial.
Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

g/mol

Enter the chemical formula of a compound to calculate its molar mass and elemental composition

Tip: Chemical formula is case sensitive: C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed n the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

bottom

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.

Keywords

GSK1838705A 1116235-97-2 Angiogenesis MAPK PI3K/Akt/mTOR signaling Tyrosine Kinase/Adaptors S6 Kinase ALK IGF-1R JNK CD246 Anaplastic lymphoma kinase inhibit Cluster of differentiation 246 Anaplastic lymphoma kinase (ALK) ALK tyrosine kinase receptor GSK-1838705A Inhibitor Insulin Receptor inhibitor

 

TargetMol